you are here:

Sun Pharmaceutical Industries Ltd.

BSE: 524715 | NSE: SUNPHARMA |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE044A01036 | SECTOR: Pharmaceuticals

BSE Live

Apr 09, 16:00
636.95 22.65 (3.69%)
Volume
AVERAGE VOLUME
5-Day
396,190
10-Day
268,679
30-Day
311,711
886,467
  • Prev. Close

    614.30

  • Open Price

    615.00

  • Bid Price (Qty.)

    636.95 (50)

  • Offer Price (Qty.)

    636.95 (695)

NSE Live

Apr 09, 15:59
636.75 22.50 (3.66%)
Volume
AVERAGE VOLUME
5-Day
7,506,826
10-Day
6,394,829
30-Day
6,307,160
16,755,446
  • Prev. Close

    614.25

  • Open Price

    613.00

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    636.75 (2197)

Financials

2020 2019 2018 2017 2016
Half Yearly Results of Sun Pharmaceutical Industries (in Rs. Cr.) Sep '20 Mar '20 Sep '19 Mar '19 Sep '18  
Net Sales/Income from operations 6,085.88 5,671.24 6,235.50 4,450.21 4,750.03  
Other Operating Income 169.67 178.39 446.80 363.18 156.74  
Total Income From Operations 6,255.55 5,849.63 6,682.30 4,813.39 4,906.77  
EXPENDITURE  
Consumption of Raw Materials 1,852.14 1,714.33 1,487.38 1,647.46 1,060.72  
Purchase of Traded Goods 527.55 622.00 605.41 544.13 632.26  
Increase/Decrease in Stocks -150.76 -50.89 189.49 -246.29 -5.01  
Power & Fuel -- -- -- -- --  
Employees Cost 918.35 843.31 859.46 817.20 750.34  
Depreciation 288.16 286.84 274.72 266.24 263.55  
Excise Duty -- -- -- -- --  
Admin. And Selling Expenses -- -- -- -- --  
R & D Expenses -- -- -- -- --  
Provisions And Contingencies -- -- -- -- --  
Exp. Capitalised -- -- -- -- --  
Other Expenses 1,598.76 1,786.53 1,763.26 1,317.78 1,902.72  
P/L Before Other 1,221.35 647.51 1,502.58 466.87 302.19  
Other Income 94.37 1,234.01 276.91 706.99 564.45  
P/L Before Int. 1,315.72 1,881.52 1,779.49 1,173.86 866.64  
Interest 82.32 236.29 171.72 252.75 288.17  
P/L Before Exceptional Items & Tax 1,233.40 1,645.23 1,607.77 921.11 578.47  
Exceptional Items -- -- -- -- -1,214.38  
P/L Before Tax 1,233.40 1,645.23 1,607.77 921.11 -635.91  
Tax -23.36 20.62 21.24 -108.27 11.12  
P/L After Tax from Ordinary Activities 1,256.76 1,624.61 1,586.53 1,029.38 -647.03  
Prior Year Adjustments -- -- -- -- --  
Extra Ordinary Items -- -- -- -- --  
Net Profit/(Loss) For the Period 1,256.76 1,624.61 1,586.53 1,029.38 -647.03  
Equity Share Capital 239.93 239.93 239.93 239.93 239.93  
Reserves Excluding Revaluation Reserves -- -- -- -- --  
Equity Dividend Rate (%) -- -- -- -- --  
EPS Before Extra Ordinary  
Basic EPS 5.24 6.77 6.61 -- -2.70  
Diluted EPS 5.24 -- 6.61 -- -2.70  
EPS After Extra Ordinary  
Basic EPS. 5.24 6.77 6.61 -- -2.70  
Diluted EPS. 5.24 -- 6.61 -- -2.70  
Public Share Holding  
No Of Shares (Crores) -- -- -- -- --  
Share Holding (%) -- -- -- -- --  
Promoters and Promoter Group Shareholding  
a) Pledged/Encumbered  
- Number of shares (Crores) -- -- -- -- --  
- Per. of shares (as a % of the total sh. of prom. and promoter group) -- -- -- -- --  
- Per. of shares (as a % of the total Share Cap. of the company) -- -- -- -- --  
b) Non-encumbered  
- Number of shares (Crores). -- -- -- -- --  
- Per. of shares (as a % of the total sh. of prom. and promoter group). -- -- -- -- --  
- Per. of shares (as a % of the total Share Cap. of the company). -- -- -- -- --  
Source : Dion Global Solutions Limited